Acg Wealth Meridian Bioscience Inc Transaction History

Acg Wealth

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$23.75 - $31.69 $12,350 - $16,478	-520 Reduced 4.89%	10,120 $308,000
Q3 2021 Nov 01, 2021	BUY	$17.35 - $22.5 $13,012 - $16,875	750 Added 7.58%	10,640 $205,000
Q2 2021 Aug 06, 2021	BUY	$18.01 - $28.32 $33,318 - $52,392	1,850 Added 23.01%	9,890 $219,000
Q1 2021 May 03, 2021	BUY	$19.76 - $29.89 $158,870 - $240,315	8,040 New	8,040 $211,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

Stay updated on Acg Wealth with notifications on news.